Ceftriaxone
- Product NDC
- 44567-701
- 11-digit product format
- 445670701
- Labeler code
- 44567
- Product ID
- 44567-701_2df28150-03a9-49bb-b4b4-0c30129723b2
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ceftriaxone
- Dosage form
- INJECTION, POWDER, FOR SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Labeler
- WG Critical Care, LLC
- Application
- ANDA065329
- Marketing category
- ANDA
- Marketing start
- 2008-07-24
- Substance
- CEFTRIAXONE SODIUM
- Active strength
- 1 g/1
- Pharmacologic classes
- Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A065329-001 | CEFTRIAXONE | CEFTRIAXONE SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-07-24 | |
| A065329-002 | CEFTRIAXONE | CEFTRIAXONE SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-07-24 | |
| A065329-003 | CEFTRIAXONE | CEFTRIAXONE SODIUM | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-07-24 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A065329-001 | AP |
| A065329-002 | AP |
| A065329-003 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A065329-001 | CEFTRIAXONE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-07-24 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A065329-002 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-07-24 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A065329-003 | CEFTRIAXONE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-07-24 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A065329-001 | CEFTRIAXONE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-07-24 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A065329-002 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-07-24 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A065329-003 | CEFTRIAXONE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-07-24 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A065329-001 | CEFTRIAXONE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-07-24 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A065329-002 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-07-24 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A065329-003 | CEFTRIAXONE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-07-24 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A065329-001 | CEFTRIAXONE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-07-24 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A065329-002 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-07-24 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A065329-003 | CEFTRIAXONE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-07-24 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A065329-001 | CEFTRIAXONE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-07-24 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A065329-002 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-07-24 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A065329-003 | CEFTRIAXONE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-07-24 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A065329-001 | CEFTRIAXONE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-07-24 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A065329-002 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-07-24 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A065329-003 | CEFTRIAXONE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-07-24 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A065329-001 | CEFTRIAXONE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-07-24 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A065329-002 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-07-24 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A065329-003 | CEFTRIAXONE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-07-24 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A065329-001 | CEFTRIAXONE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-07-24 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A065329-002 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-07-24 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A065329-003 | CEFTRIAXONE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-07-24 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A065329-001 | CEFTRIAXONE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-07-24 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A065329-002 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-07-24 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A065329-003 | CEFTRIAXONE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-07-24 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A065329-001 | CEFTRIAXONE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-07-24 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A065329-002 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-07-24 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A065329-003 | CEFTRIAXONE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-07-24 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A065329-001 | CEFTRIAXONE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-07-24 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A065329-002 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-07-24 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A065329-003 | CEFTRIAXONE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-07-24 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A065329-001 | CEFTRIAXONE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-07-24 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A065329-002 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-07-24 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A065329-003 | CEFTRIAXONE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-07-24 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A065329-001 | CEFTRIAXONE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-07-24 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A065329-002 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-07-24 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A065329-003 | CEFTRIAXONE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-07-24 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A065329-001 | CEFTRIAXONE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-07-24 | 301d65b070ca… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A065329-001 | AP | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A065329-002 | AP | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A065329-003 | AP | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A065329-001 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A065329-002 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A065329-003 | AP | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A065329-001 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A065329-002 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A065329-003 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A065329-001 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A065329-002 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A065329-003 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A065329-001 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A065329-002 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A065329-003 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A065329-001 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A065329-002 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A065329-003 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A065329-001 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A065329-002 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A065329-003 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A065329-001 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A065329-002 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A065329-003 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A065329-001 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A065329-002 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A065329-003 | AP | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A065329-001 | AP | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A065329-002 | AP | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A065329-003 | AP | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A065329-001 | AP | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A065329-002 | AP | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A065329-003 | AP | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A065329-001 | AP | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A065329-002 | AP | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A065329-003 | AP | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A065329-001 | AP | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A065329-002 | AP | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A065329-003 | AP | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A065329-001 | AP | 1 | 301d65b070ca… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Ceftriaxone
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| CEFTRIAXONE SODIUM | 1 g/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 023Z5BR09K | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 7bed9b33-29e3-4f04-9766-43a21c7ad47a | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 67ae10d0-6c6a-4d52-a629-da83321859b9 | Product name | 3 | 20190201 |
| 01b0d089-049b-4c6d-8dfe-1bffad9be307 | Product name | 2 | 20180807 |
| 2d5083fe-71de-4fce-8d67-e9049cba775c | Product name | 1 | 20150107 |
| 1037f4ca-3bea-c9c4-2af4-fa6387b0e81e | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 44567-701-25 | Ceftriaxone | 1 in 1 VIAL | INJECTION, POWDER, FOR SOLUTION | 1 | 19 | |
| 44567-701-25 | Ceftriaxone | 25 in 1 CARTON | INJECTION, POWDER, FOR SOLUTION | 25 | 19 | |
| 44567-701-95 | Ceftriaxone | 25 in 1 CARTON | INJECTION, POWDER, FOR SOLUTION | 25 | 5 | |
| 44567-701-95 | Ceftriaxone | 1 in 1 VIAL | INJECTION, POWDER, FOR SOLUTION | 1 | 5 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 44567-701-25 | EA - Each | 44567-701 | c85fbf91-f15b-4cd1-b832-cf39d4265a7b | 1 | 2013-05-02 |
| 44567-701-95 | EA - Each | 44567-701 | 74c4c8e1-e5cd-4427-8674-b8a33f4de88e | 1 | 2023-06-06 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| CEFTRIAXONE SODIUM | ACTIVE INGREDIENT | 023Z5BR09K | CEFTRIAXONE INJECTION, POWDER, FOR SOLUTION [WG CRITICAL CARE, LLC] | 6 | |
| CEFTRIAXONE | ACTIVE MOIETY | 75J73V1629 | CEFTRIAXONE INJECTION, POWDER, FOR SOLUTION [WG CRITICAL CARE, LLC] | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 44567-701 | CEFTRIAXONE INJECTION, POWDER, FOR SOLUTION [WG CRITICAL CARE, LLC] | 19 | Current NDC, Legacy NDC, 2 package rows | 20250409_befd73ff-cb3b-4543-8a8e-bdb9b7fc1ff0.zip |
| 44567-701 | CEFTRIAXONE INJECTION, POWDER, FOR SOLUTION [WG CRITICAL CARE, LLC] | 4 | Current NDC, Legacy NDC, 2 package rows | 20250410_7bed9b33-29e3-4f04-9766-43a21c7ad47a.zip |
| 44567-701 | EASY-CEFT 1G (CEFTRIAXONE) KIT [AMERICAN HEALTH RX, LLC] | 1 | Current NDC, Legacy NDC | 20210615_b854d54e-46c2-58c0-e053-2a95a90abb4a.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ceftriaxone | CEFTRIAXONE | WG Critical Care, LLC | 7bed9b33-29e3-4f04-9766-43a21c7ad47a | 2026-01-07 | Warnings, Adverse reactions | 065329 ANDA065329 44567-701 |
| Ceftriaxone | CEFTRIAXONE | WG Critical Care, LLC | befd73ff-cb3b-4543-8a8e-bdb9b7fc1ff0 | 2025-04-07 | Warnings, Adverse reactions | 065329 ANDA065329 44567-701 |
| ceftriaxone | CEFTRIAXONE | Sagent Pharmaceuticals | 5cf93bc5-9e4c-4734-bc02-c7d0ac071022 | 2023-11-08 | Warnings, Adverse reactions | 065329 ANDA065329 |
| Ceftriaxone | CEFTRIAXONE | Fresenius Kabi USA, LLC | 7ea1db43-40fa-417b-8911-ae98092070a0 | 2023-09-30 | Warnings, Adverse reactions | 065329 ANDA065329 |
| Ceftriaxone | CEFTRIAXONE | Proficient Rx LP | fcf401df-bcdc-4773-a63b-9741c0f74b3d | 2022-11-01 | Warnings, Adverse reactions | 065329 ANDA065329 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1665021 | cefTRIAXone 1 GM Injection | PSN | befd73ff-cb3b-4543-8a8e-bdb9b7fc1ff0 | 19 |
| 1665046 | cefTRIAXone 2 GM Injection | PSN | befd73ff-cb3b-4543-8a8e-bdb9b7fc1ff0 | 19 |
| 1665005 | cefTRIAXone 500 MG Injection | PSN | befd73ff-cb3b-4543-8a8e-bdb9b7fc1ff0 | 19 |
| 1665021 | ceftriaxone 1000 MG Injection | SCD | befd73ff-cb3b-4543-8a8e-bdb9b7fc1ff0 | 19 |
| 1665046 | ceftriaxone 2000 MG Injection | SCD | befd73ff-cb3b-4543-8a8e-bdb9b7fc1ff0 | 19 |
| 1665005 | ceftriaxone 500 MG Injection | SCD | befd73ff-cb3b-4543-8a8e-bdb9b7fc1ff0 | 19 |
| 1665021 | ceftriaxone 1 GM (as ceftriaxone sodium) Injection | SY | befd73ff-cb3b-4543-8a8e-bdb9b7fc1ff0 | 19 |
| 1665046 | ceftriaxone 2 GM (as ceftriaxone sodium) Injection | SY | befd73ff-cb3b-4543-8a8e-bdb9b7fc1ff0 | 19 |
| 1665005 | ceftriaxone 500 MG (as ceftriaxone sodium) Injection | SY | befd73ff-cb3b-4543-8a8e-bdb9b7fc1ff0 | 19 |
| 1665021 | cefTRIAXone 1 GM Injection | PSN | 7bed9b33-29e3-4f04-9766-43a21c7ad47a | 5 |
| 1665046 | cefTRIAXone 2 GM Injection | PSN | 7bed9b33-29e3-4f04-9766-43a21c7ad47a | 5 |
| 1665021 | ceftriaxone 1000 MG Injection | SCD | 7bed9b33-29e3-4f04-9766-43a21c7ad47a | 5 |
| 1665046 | ceftriaxone 2000 MG Injection | SCD | 7bed9b33-29e3-4f04-9766-43a21c7ad47a | 5 |
| 1665021 | ceftriaxone 1 GM (as ceftriaxone sodium) Injection | SY | 7bed9b33-29e3-4f04-9766-43a21c7ad47a | 5 |
| 1665046 | ceftriaxone 2 GM (as ceftriaxone sodium) Injection | SY | 7bed9b33-29e3-4f04-9766-43a21c7ad47a | 5 |
| 1665021 | cefTRIAXone 1 GM Injection | PSN | b854d54e-46c2-58c0-e053-2a95a90abb4a | 1 |
| 1665021 | ceftriaxone 1000 MG Injection | SCD | b854d54e-46c2-58c0-e053-2a95a90abb4a | 1 |
| 1665021 | ceftriaxone 1 GM (as ceftriaxone sodium) Injection | SY | b854d54e-46c2-58c0-e053-2a95a90abb4a | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 44567-701-25 | 44567070125 | 25 VIAL in 1 CARTON (44567-701-25) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL | 25 vial | 2008-07-24 | 0000-00-00 | No | No | Current |
| 44567-701-95 | 44567070195 | 25 VIAL in 1 CARTON (44567-701-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL | 25 vial | 2023-01-05 | 0000-00-00 | No | No | Current |